TR199801935T2 - Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. - Google Patents

Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.

Info

Publication number
TR199801935T2
TR199801935T2 TR1998/01935T TR9801935T TR199801935T2 TR 199801935 T2 TR199801935 T2 TR 199801935T2 TR 1998/01935 T TR1998/01935 T TR 1998/01935T TR 9801935 T TR9801935 T TR 9801935T TR 199801935 T2 TR199801935 T2 TR 199801935T2
Authority
TR
Turkey
Prior art keywords
pyrrolopyrrolon
inhibitors
derivatives
neutrophil elastase
compounds
Prior art date
Application number
TR1998/01935T
Other languages
English (en)
Inventor
Dennis Dowle Michael
Finch Harry
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Shah Pritom
Andrew Smith Robin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199801935T2 publication Critical patent/TR199801935T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Bu bulusa göre (I) formülünün (görece stereo-kimyasi belirtilen) bilesikleri bu bilesiklerin hazirlanmasi için islem ile birlikte anlatilmis, bu bilesikleri ihtiva eden bilesimler ve bunlarin farmasötik maddeler olarak kullanimlari anlatilmistir, bu formülde, R1,R2,R3 ve X tarifnamede tanimlandigi gibidir. (I) formülünün bilesikleri, diger hususlarin yanisira kronik bronsitin tedavisi için ortaya konmustur.
TR1998/01935T 1996-03-28 1997-03-26 Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. TR199801935T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds

Publications (1)

Publication Number Publication Date
TR199801935T2 true TR199801935T2 (tr) 1999-03-22

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01935T TR199801935T2 (tr) 1996-03-28 1997-03-26 Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.

Country Status (30)

Country Link
US (3) US5994344A (tr)
EP (1) EP0891362B1 (tr)
JP (1) JP4118337B2 (tr)
KR (1) KR20000005039A (tr)
CN (1) CN1067075C (tr)
AP (1) AP823A (tr)
AR (1) AR006401A1 (tr)
AT (1) ATE261969T1 (tr)
AU (1) AU726649B2 (tr)
BR (1) BR9708449A (tr)
CA (1) CA2250209A1 (tr)
CO (1) CO4790152A1 (tr)
CZ (1) CZ309798A3 (tr)
DE (1) DE69728139T2 (tr)
DK (1) DK0891362T3 (tr)
EA (1) EA001437B1 (tr)
EE (1) EE9800335A (tr)
ES (1) ES2217404T3 (tr)
HU (1) HUP9900567A3 (tr)
IL (1) IL125859A0 (tr)
IS (1) IS4837A (tr)
NO (1) NO984470L (tr)
NZ (1) NZ331490A (tr)
PE (1) PE55298A1 (tr)
PL (1) PL329153A1 (tr)
PT (1) PT891362E (tr)
SK (1) SK132498A3 (tr)
TR (1) TR199801935T2 (tr)
WO (1) WO1997036903A1 (tr)
YU (1) YU41198A (tr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719172D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
CA2517888C (en) 2003-03-14 2012-05-01 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
TWI400232B (zh) 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
EP3006425A1 (en) * 2007-04-23 2016-04-13 Siga Technologies, Inc. Pharmaceutical composition for use in the treatment and prevention of orthopoxvirus infections and associated diseases
US8119809B2 (en) 2007-11-16 2012-02-21 Rigel Pharmaceuticals, Inc. AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
ES2553340T3 (es) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
CN112079769A (zh) 2008-04-23 2020-12-15 里格尔药品股份有限公司 用于治疗代谢障碍的甲酰胺化合物
NZ709153A (en) * 2012-12-18 2019-01-25 Chiesi Farm Spa Pyrimidinone derivatives having human neutrophil elastase inhibitory activity
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
EP4252850A3 (en) 2020-04-16 2023-11-15 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
ATE261969T1 (de) 2004-04-15
YU41198A (sh) 1999-09-27
CZ309798A3 (cs) 1999-02-17
EP0891362B1 (en) 2004-03-17
AU2291797A (en) 1997-10-22
IL125859A0 (en) 1999-04-11
AP823A (en) 2000-04-25
US5994344A (en) 1999-11-30
DK0891362T3 (da) 2004-07-12
SK132498A3 (en) 1999-08-06
JP2000507950A (ja) 2000-06-27
EP0891362A1 (en) 1999-01-20
EE9800335A (et) 1999-04-15
EA199800773A1 (ru) 1999-06-24
CO4790152A1 (es) 1999-05-31
AU726649B2 (en) 2000-11-16
HUP9900567A2 (hu) 1999-06-28
AR006401A1 (es) 1999-08-25
EA001437B1 (ru) 2001-02-26
CA2250209A1 (en) 1997-10-09
PL329153A1 (en) 1999-03-15
US6057457A (en) 2000-05-02
KR20000005039A (ko) 2000-01-25
PE55298A1 (es) 1998-09-19
AP9801351A0 (en) 1998-09-30
JP4118337B2 (ja) 2008-07-16
BR9708449A (pt) 1999-08-03
HUP9900567A3 (en) 2001-02-28
IS4837A (is) 1998-08-28
WO1997036903A1 (en) 1997-10-09
CN1219935A (zh) 1999-06-16
NO984470D0 (no) 1998-09-25
PT891362E (pt) 2004-08-31
US6215002B1 (en) 2001-04-10
DE69728139D1 (de) 2004-04-22
ES2217404T3 (es) 2004-11-01
NO984470L (no) 1998-11-25
DE69728139T2 (de) 2004-10-21
CN1067075C (zh) 2001-06-13
NZ331490A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
TR199801935T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
DE69417012D1 (de) Cyclobutan-derivate als inhibitoren der squalen-synthetase und der protein-farnesyltransferase
TR200101884T2 (tr) Farnesil transferaz inhibitörleri olarak 4-merkaptopirolidin türevleri.
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
TR199801244T2 (tr) Herpese karsi özellikler tasiyan fenil tiyazol türevleri.
TR199900920T2 (tr) Nafthiridin türevleri.
TR199802344A2 (tr) Ikame edilmis imidazolidin türevleri
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
TR199901765T2 (tr) Sülfomid-metalloproteaz inhibitörleri
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
TR199902995T2 (tr) 9-Oksim eritromisin türevleri
DE69127690T2 (de) Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate
GB0011203D0 (en) Chemical compounds
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
DE69130326D1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
CA2218663A1 (en) Benzisoxazole and indazole derivatives as antipsychotic agents
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
BRPI0416674A (pt) tiazolidinona amidas, amidas de ácido tiazolidino carboxìlico, processos de fabricação, e uso das mesmas
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
TR200003797T2 (tr) Alfa-D-ksiloz'dan türetilen yeni terkipler, bunların hazırlanma yöntemleri ve tedavi maksatlı kullanımları.